Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016-2022.
The epidemiology of allergic bronchopulmonary aspergillosis (ABPA) in the United States is not well-described. To estimate national ABPA prevalence among patients with asthma or cystic fibrosis, characterize ABPA testing practices, and describe ABPA clinical features, treatment, and 6-month outcomes...
Saved in:
Main Authors: | Kaitlin Benedict, Jeremy A W Gold, Mitsuru Toda, Joy Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0317054 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and features of allergic bronchopulmonary aspergillosis, United States, 2016–2022
by: Kaitlin Benedict, et al.
Published: (2025-01-01) -
Allergic Bronchopulmonary Aspergillosis with an Atypical Mass-Like Presentation
by: Mahmoud Ibrahim Mahmoud, et al.
Published: (2022-01-01) -
Coexistence of Asymptomatic Allergic Bronchopulmonary Aspergillosis and Active Pulmonary Tuberculosis: Case Report
by: Jia Q, et al.
Published: (2025-01-01) -
Revised clinical practice guidelines for allergic bronchopulmonary aspergillosis/mycosis: A detailed and comprehensive update
by: Jiayan Xu, et al.
Published: (2025-02-01) -
Invasive Aspergillosis in the Intensive Care Unit
by: Anna Zubovskaia, et al.
Published: (2025-01-01)